Keith Tennison

Vice President

Professional Overview
Keith Tennison is an accomplished pharmaceutical executive with over 20 years of experience in the industry. He currently serves as the Vice President at KalVista Pharmaceuticals, Inc., where he is responsible for driving the company's market access strategy and expanding its reach in the epilepsy and rare syndromes therapeutic areas.

Experience Summary

Current Role
As Vice President at KalVista Pharmaceuticals, Inc., Keith is spearheading the company's market access initiatives, ensuring that its innovative therapies are accessible to patients in need. He is leveraging his extensive expertise in market access, stakeholder management, and strategic planning to position the company for long-term success.

Career Progression
Prior to his current role, Keith held several leadership positions at prominent pharmaceutical companies. He served as the Head of Market Access Strategy for Epilepsy and Rare Syndromes at UCB, where he developed and implemented impactful market access strategies that improved patient access to critical treatments. Before that, he held various roles at Sunovion Pharmaceuticals, including Director of Health System Accounts, Market Access, and Director of Business Operations, Market Access. In these positions, he demonstrated his ability to drive strategic initiatives, enhance operational efficiency, and foster strong partnerships with healthcare stakeholders.

Keith began his pharmaceutical career at Pfizer, where he gained valuable experience in operations and specialty sales, further honing his skills in the industry.

Academic Background
Keith holds a Bachelor's degree from the University of Massachusetts, Amherst, where he majored in Business Administration with a concentration in Marketing.

Areas of Expertise

• Market access strategy development and implementation

• Stakeholder management and collaboration

• Cross-functional team leadership

• Operational excellence and process optimization

• Strategic planning and business development

Professional Impact
During his tenure at UCB, Keith played a pivotal role in expanding patient access to epilepsy and rare syndrome treatments, leading to improved health outcomes for thousands of individuals. At Sunovion Pharmaceuticals, his strategic initiatives and operational enhancements contributed to the company's overall growth and market position.

Conclusion
With his extensive experience, strategic mindset, and proven track record of success, Keith Tennison is poised to drive meaningful impact in his role as Vice President at KalVista Pharmaceuticals, Inc. His deep industry expertise and commitment to improving patient access to innovative therapies position him as a valuable asset to the company and the broader pharmaceutical industry.